Genmab | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Almirall EUR -2102000 17.27M 2024-12
Amarin USD -21529000 24.42M 2024-09
Amgen USD 3.38B 111M 2024-12
argenx SE USD 88.02M 103.02M 2024-09
AstraZeneca USD 3.4B 1.74B 2025-03
Bayer EUR 1.83B 2.31B 2025-03
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Demant DKK 967M 76M 2024-12
Exelixis USD 205.69M 20.92M 2025-03
Fresenius Medical Care EUR 179.93M 201.07M 2024-12
Galapagos EUR -156367000 175.4M 2025-03
Genmab DKK 244M 3.36B 2025-03
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
GN Store Nord DKK 114M 93M 2025-03
GRIFOLS EUR 210.54M 143.56M 2024-12
Hikma Pharmaceutical USD 144M 144M 2024-06
Insmed USD -255671000 21.39M 2025-03
Lonza CHF 427M 167M 2024-06
Merck EUR 809M 425.38M 2024-12
Novartis USD 4.66B 269M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
UCB EUR 123M 464.07M 2024-06



Genmab L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.